MILOSO MARIAROSARIA
- U08, Piano: 1, Stanza: 1030
Pubblicazioni
Naghshbandieh, A., D'Aprile, C., Donzelli, E., Rodriguez Menendez, V., Meregalli, C., Miloso, M., et al. (2026). Chemotherapy Effect on Human iPSC-Derived Sensory Neurons. In 79° Congresso Nazionale SIAI (pp.132-132). Dettaglio
Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation. Intervento presentato a: 2025 PNS Annual Meeting, Edinburgh, Scotland. Dettaglio
Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy. Intervento presentato a: NeuroMi 2025: Milan Center for Neuroscience, Milano, Italia. Dettaglio
Cavalloro, V., Malacrida, A., Miloso, M., Ronchi, D., Porta, A., Fossati, A., et al. (2025). From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation. BIOMÉDECINE & PHARMACOTHÉRAPIE, 188(July 2025), 1-10 [10.1016/j.biopha.2025.118208]. Dettaglio
Fermi, S., Malacrida, A., Molteni, L., Tarasiuk, O., Miloso, M., Cavaletti, G., et al. (2024). Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity. In Abstracts of the Fourteenth Annual Meeting of the Associazione italiana per lo studio del Sistema Nervoso Periferico (ASNP), 30 May – 1 June 2024, Trieste, Italy. Dettaglio